The introduction of biologics and updated understanding of asthma as a disease has changed our treatment approach to a more tailored, personalized strategy. This activity will take you through a pathophysiology-guided understanding of the various agents’ pharmacology. It will dive into a side-by-side exploration of safety and efficacy data for new and emerging treatments for asthma, reinforced by clinical case scenarios, expert commentary, interactive tools, and downloadable resources—all packaged and delivered in a visually impactful infographic design.
Upon completion of this activity, participants should be better able to:
Vice Chancellor, Translational Medicine and Science
Director, Rutgers Institute for Translational Medicine and Science
Professor of Medicine, Rutgers University
New Brunswick, NJ
Emeritus Professor, Medicine
University of Pennsylvania
Philadelphia, PA
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
